I expect that you are correct. Given that CHIRON will be decommissioned at the end of March 2015 there will still be some 9 months revenue for FY15. It seems reasonable to expect that other revenue growth in FY 2015 will cover the loss.
FY16 will see a the full year of loss of Revenue from CHIRON which GLH have estimated at 1.5cps. So FY 16 NPAT looks like it will be lower than FY15 or flat at best.
Ann: SA Health Termination of CHIRON, page-8
Add GLH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $7.836M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $6.465K | 48.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39384 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 1585 | 1 |
View Market Depth
| Last trade - 15.35pm 29/11/2024 (20 minute delay) ? |
| GLH (ASX) Chart |
